QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer's disease

2 weeks ago

QIAGEN to develop the first QIAstat-Dx IVD panel for neurodegenerative applications // New QIAstat-Dx panel to identify APOE genotypes, one of many factors considered in the diagnosis of patients with Alzheimer's Disease // Collaboration set to launch the first commercially available IVD Kit for ...

Ticker	Sentiment	Impact
QGEN	Somewhat Bullish	37 %